OPINION
NEWS
REGIONS
WORLD
BUSINESS
SPORTS
ENTERTAINMENT
LIFESTYLE
THE SUNDAY TIMES
SPECIAL FEATURES
SPECIAL SECTIONS
TMT NEWSWIRE
FAST TIMES
LEGAL ADVICE
CAMPUS PRESS
VIDEOS
EXPATS & DIPLOMATS
PHOTOS
BUSINESS FORUM
PODCASTS
RESOURCES
WEATHER
MARKET OVERVIEW
EXAM RESULTS
TMT CSI
TMT DIGITAL EDITION
GAMES
TMT 125TH ANNIVERSARY
QUIZZES
TMT Newswire > PR Newswire
Antengene to Present Results from Three Programs at the 2024 SITC Annual Meeting
by PR Newswire
Oct 07, 2024 1:35 pm

SHANGHAI and HONG KONG, Oct. 5, 2024 /PRNewswire/ -- Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announced that it will present three programs at the 2024 Society of Immunology in Cancer Annual Meeting (SITC 2024) to be held in Houston from November 6-10, 2024.

Register to unlock this article

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here

Related Articles

iKala KOL Radar Surpasses 300 Million Influencers, Leading Global Cross-Border Influencer Marketing with AI

SJM Showcases Macau's Offerings to Global Corporate Travellers at Trip.Biz Business Travel Summit 2024 in Korea

TreeToTextile and Lenzing join forces for next-generation cellulose fibers

Lithium Africa Resources Corp. ("Lithium Africa" or the "Company") announces additions to board

Lithium Africa Resources Corp. ("Lithium Africa" or the "Company") announces additions to board

Sinch Honored with Frost & Sullivan's Enlightened Growth Leadership Award

Fleet Management Limited Appoints Chief Executive Officer